Nrx Pharmaceuticals Inc (NRXP)
2.00 x 5 2.06 x 2
Pre-market by (Cboe BZX)
2.06 -0.04 (-1.90%) 04/29/25 [NASDAQ]
2.00 x 5 2.06 x 2
Pre-market 2.06 unch (unch) 09:00 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NRXP | ITRM | SRZN | ||
| Company | Nrx Pharmaceuticals Inc | Iterum Therapeutics Plc | Consonance-Hfw Acq Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.07 | 1.0900 | 10.50 | ||
| High | 2.07 | 1.0900 | 10.50 | ||
| Low | 2.07 | 1.0900 | 10.14 | ||
| Last | 2.07 | 1.0900 | 10.44 | ||
| Change | +0.01 | +0.0300 | +0.05 | ||
| % Change | +0.73% | +2.83% | +0.52% | ||
| Volume | 2,490 | 22,172 | 3,100 | ||
| 20-Day Average Volume | 104,575 | 416,364 | 10,035 | ||
| Previous Close | 2.06 | 1.0600 | 10.38 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.94 | 1.1475 | 10.08 | ||
| 20-Day Raw Stochastic | 87.50% | 19.51% | 39.12% | ||
| 20-Day Relative Strength | 49.75% | 42.58% | 49.29% | ||
| Weighted Alpha | -66.20 | -46.74 | -7.56 | ||
| Today's Opinion | 8% Sell | 88% Sell | 24% Sell | ||
| Previous Opinion | 8% Sell | 88% Sell | 24% Sell | ||
| Last Month's Opinion | 8% Sell | 72% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.55% since 04/23/25 | -21.58% since 04/23/25 | +4.48% since 04/22/25 | ||
| Low | 1.95 on 04/24/25 | 1.0200 on 04/29/25 | 9.51 on 04/25/25 | ||
| High | 2.11 on 04/29/25 | 1.3600 on 04/24/25 | 10.57 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +1.97% since 03/28/25 | -13.49% since 03/28/25 | -5.20% since 03/28/25 | ||
| Low | 1.58 on 04/07/25 | 1.0100 on 04/21/25 | 8.84 on 04/09/25 | ||
| High | 2.14 on 04/14/25 | 1.4200 on 04/23/25 | 12.93 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -30.77% since 01/30/25 | -30.57% since 01/30/25 | -7.22% since 01/29/25 | ||
| Low | 1.58 on 04/07/25 | 1.0100 on 04/21/25 | 8.84 on 04/09/25 | ||
| High | 3.44 on 02/06/25 | 1.7500 on 01/31/25 | 14.00 on 03/24/25 | ||
| 6-Month | |||||
| %Chg | +44.76% since 10/30/24 | -9.92% since 10/30/24 | +9.87% since 10/29/24 | ||
| Low | 1.12 on 11/14/24 | 1.0100 on 04/21/25 | 8.10 on 11/19/24 | ||
| High | 6.01 on 01/13/25 | 3.0200 on 12/09/24 | 18.17 on 01/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,762 | 36,656 | 34,248 | ||
| Shares Outstanding, K | 16,916 | 34,581 | 3,281 | ||
| Annual Sales | 0 | 0 | 10,660,000 | ||
| Annual Net Income | -25,130,000 | -24,770,000 | -63,560,000 | ||
| Last Quarter Sales | 0 | 0 | 650,000 | ||
| Last Quarter Net Income | -9,080,000 | -6,580,000 | -28,040,000 | ||
| 60-Month Beta | 1.41 | 2.87 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 03/14/25 | -0.12 on 02/07/25 | -9.10 on 03/31/25 | ||
| Latest Earnings Date | 05/13/25 | 05/12/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||